n,n'-bis(pyridoxal-5-phosphate)ethylenediamine-n,n'-diacetic acid has been researched along with Reperfusion Injury in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Batteux, F; Bedda, S; Chereau, C; Coriat, R; Goulvestre, C; Kavian, N; Laurent, A; Leconte, M; Nicco, C; Weill, B | 1 |
1 other study(ies) available for n,n'-bis(pyridoxal-5-phosphate)ethylenediamine-n,n'-diacetic acid and Reperfusion Injury
Article | Year |
---|---|
Mangafodipir protects against hepatic ischemia-reperfusion injury in mice.
Topics: Animals; Apoptosis; Aspartate Aminotransferases; Edetic Acid; Female; Glutathione; Ischemic Preconditioning; Lipid Peroxidation; Liver; Mice; Mice, Inbred BALB C; Pyridoxal Phosphate; Reactive Oxygen Species; Reperfusion Injury; Survival Rate | 2011 |